A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis.

A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis.
复制标题

DOI:
10.1016/j.cell.2014.10.032
复制
发表时间:
2014-11-06
期刊:
影响因子:
64.5
通讯作者:
MacBeath G
MacBeath G
中科院分区:
生物学1区
文献类型:
--
作者:
Gujral TS;Chan M;Peshkin L;Sorger PK;Kirschner MW;MacBeath G

文献摘要

参考文献

被引文献

相似文献

Wnt信号在胚胎发育中起着关键作用,该网络中的遗传畸变与结直肠癌有广泛的关系。我们发现Wnt受体Frizzled 2(Fzd 2)及其配体Wnt 5a/B在转移性肝癌、肺癌、结肠癌和乳腺癌细胞系以及高级别肿瘤中升高,并且它们的表达与上皮-间质转化(EMT)标志物相关。药理学和遗传学的扰动表明,Fzd 2驱动EMT和细胞迁移通过一个以前未认识的,非经典的途径,包括Fyn和Stat 3。由该途径调节的基因特征可预测患者的转移和总生存期。我们已经开发了一种Fzd 2抗体,可减少细胞迁移和侵袭,并抑制异种移植物中的肿瘤生长和转移。我们认为,靶向这一途径可以为表达高水平Fzd 2的肿瘤患者提供益处。
Wnt signaling plays a critical role in embryonic development, and genetic aberrations in this network have been broadly implicated in colorectal cancer. We find that the Wnt receptor Frizzled2 (Fzd2) and its ligands Wnt5a/b are elevated in metastatic liver, lung, colon, and breast cancer cell lines and in high-grade tumors, and that their expression correlates with markers of epithelial-mesenchymal transition (EMT). Pharmacologic and genetic perturbations reveal that Fzd2 drives EMT and cell migration through a previously unrecognized, non-canonical pathway that includes Fyn and Stat3. A gene signature regulated by this pathway predicts metastasis and overall survival in patients. We have developed an antibody to Fzd2 that reduces cell migration and invasion and inhibits tumor growth and metastasis in xenografts. We propose that targeting this pathway could provide benefit for patients with tumors expressing high levels of Fzd2.
DOI: 10.1016/j.cell.2011.04.029
发表时间: 2011-06-10
期刊: Cell
影响因子: 64.5
作者:
Scheel C;Eaton EN;Li SH;Chaffer CL;Reinhardt F;Kah KJ;Bell G;Guo W;Rubin J;Richardson AL;Weinberg RA
通讯作者: Weinberg RA
DOI: 10.1073/pnas.1403080111
发表时间: 2014-04-01
影响因子: 11.1
作者:
Gujral, Taranjit Singh;Peshkin, Leonid;Kirschner, Marc W.
通讯作者: Kirschner, Marc W.
DOI: 10.1083/jcb.200912128
发表时间: 2010-07-26
期刊: The Journal of cell biology
影响因子: --
作者:
Lin S;Baye LM;Westfall TA;Slusarski DC
通讯作者: Slusarski DC
DOI: 10.1158/0008-5472.can-10-0244
发表时间: 2010-09-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Gupta, Santosh;Iljin, Kristiina;Kallioniemi, Olli
通讯作者: Kallioniemi, Olli
DOI: 10.1074/jbc.m700075200
发表时间: 2007-06-08
影响因子: 4.8
作者:
Dissanayake, Samudra K.;Wade, Michael;Weeraratna, Ashani T.
通讯作者: Weeraratna, Ashani T.